Cross-cloud operators are well-positioned for long-term strength regardless of the GPU, cloud, or provider behind the AI.
Once thought to be doomed by the AI revolution, robotic process automation specialist UiPath (NYSE: PATH) defied critics in ...
Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...
UiPath's AI-driven automation momentum, strong cash position and enterprise adoption stand out against Microvast's growth, losses and liquidity strain.
UiPath Inc. (NYSE:PATH) is one of the AI stocks under $20 to buy now. On December 9, Morgan Stanley analyst Sanjit Singh ...
UiPath stock was rallying Wednesday, with the automation software company set to join the S&P MidCap 400 index at the start of 2026.
Palantir has been one of the best growth stories in the market. UiPath is just beginning to see its revenue growth accelerate as it looks to become an AI agent orchestration platform. UIPath's ...
UiPath Test Cloud recognized among top autonomous testing solutions with highest possible scores in vision, roadmap, and five other criteria UiPath (NYSE: PATH), a global leader in agentic automation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results